Delivery Order SPE2DB20D2104-SPE2DB25FLZZV

Award Date 10/8/24
Potential Completion Date 10/9/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,188.80 firm fixed-price delivery order is for the supply of 4566401459 dexamethasone 10 mg/ml vials, with a completion date of November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,524.24, is a Firm Fixed Price Delivery Order for the supply of Dexamethasone 10 mg/ml vials. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,911,624 units of Dexamethasone 20 mg/5 ml vials, a critical medication. The order has a firm fixed price of $5,562.90 and a completion date of September 24, 2024. Amerisourcebergen, through its extensive pharmaceutical supply chain, will provide this medication to support various military treatment...
This federal contract award, valued at $1,084.49, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of dexamethasone 10 mg/ml vials. The $14,440.48 Firm Fixed Price contract is a Delivery Order that has a completion date of November 25, 2024. The contract is not designated as a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $1,454.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dexamethasone 10 mg/ml vials, a specialty medication used in various medical treatments. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,643.55 firm fixed-price delivery order is for the supply of 237 mL bottles of 0.5 mg/5 mL dexamethasone, a corticosteroid medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides...
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FN3Q6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,171.45 delivery order is for the supply of 4,556,895,922 milliliters of the drug Dexamethasone 10 mg/ml. This order is not designated as a set-aside contract. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order valued at $6,111.46 for the supply of Dexamethasone 10 mg/mL vial, a pharmaceutical product. The contract has an ultimate completion date of March 13, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,943.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564572082 - DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2024 and is a firm fixed-price delivery order. There is no set-aside designation mentioned in the award information provided....
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FLZZV
    Delivery Order

This federal contract award, with ID SPE2DB20D2104|SPE2DB25FLZZV, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,339.99 firm fixed-price delivery order is for the supply of Dexamethasone 0.5 mg/5 ml, an injectable medication, with an ultimate completion date of October 9, 2024.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is not designated with a set-aside requirement, indicating open competition. The contract award demonstrates Amerisourcebergen's extensive role in supplying essential medical commodities to federal agencies, particularly the DLA, which oversees the procurement of pharmaceuticals and medical supplies for the U.S. military and other government healthcare programs.

Generated 2/27/25, 12:23 PM